Active Biotech: Update with Tasquinimod in MM - Redeye
Bildkälla: Stockfoto

Active Biotech: Update with Tasquinimod in MM - Redeye

Redeye comments on the latest readout from the trial of tasquinimod in multiple myeloma.

Börsvärldens nyhetsbrev